Vogliheal 0.2 (Voglibose 0.2 mg)

Vogliheal 0.2 contains Voglibose (0.2 mg) an alpha-glucosidase inhibitor used in the management of type 2 diabetes. It works by delaying the digestion and absorption of carbohydrates in the intestines which helps to prevent rapid increases in blood glucose levels after meals. Vogliheal is often used in conjunction with other antidiabetic medications to enhance glycemic control and reduce postprandial hyperglycemia thereby helping to lower the risk of diabetes-related complications.